Bright Minds Biosciences Stock Performance

DRUG Stock  USD 78.64  0.89  1.14%   
On a scale of 0 to 100, Bright Minds holds a performance score of 13. The firm shows a Beta (market volatility) of 2.39, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bright Minds will likely underperform. Please check Bright Minds' potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether Bright Minds' price patterns will revert.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Bright Minds Biosciences are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, Bright Minds reported solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
1.14
Five Day Return
(7.48)
Year To Date Return
(5.78)
Ten Year Return
191.26
All Time Return
191.26
Last Split Factor
1:5
Last Split Date
2023-07-14
1
MADD Canada Unveils Roadside Memorial Sign in Trenton in Honour of Rebecca Beatty Killed in Impaired Driving Crash
11/07/2025
2
Recent Price Trend in Bright Minds Biosciences Inc. is Your Friend, Heres Why
11/26/2025
3
Permettre aux jeunes de faire des choix de conduite sobre MADD Canada et la SAPM offrent aux lves du Manitoba un Programme scolaire visant sauver des vies
12/12/2025
4
Bright Minds Biosciences Buy Rating Reaffirmed at HC Wainwright
12/30/2025
5
Chardan Capital Reaffirms Buy Rating for Bright Minds Biosciences - MarketBeat
01/02/2026
6
New Bright Minds Epilepsy Drug Cuts Seizures, Lifts Stock On Tuesday
01/06/2026
7
Bright Minds Biosciences Announces Pricing of Upsized US175 Million Public Offering of Common Stock - GlobeNewswire
01/07/2026
8
Bright Minds Biosciences Announces Closing of US175 Million Public Offering
01/09/2026
9
Hundreds arrested in drink and drug drive crackdown
01/15/2026
10
Global Protein Expression Market Poised for 10.9 percent CAGR Expansion by 2030
01/23/2026
11
Canadians Say Impaired Driving Is a Serious Public Safety Issue and Want Governments to Act
01/28/2026

Bright Minds Relative Risk vs. Return Landscape

If you would invest  5,217  in Bright Minds Biosciences on November 5, 2025 and sell it today you would earn a total of  2,647  from holding Bright Minds Biosciences or generate 50.74% return on investment over 90 days. Bright Minds Biosciences is currently generating 0.8008% in daily expected returns and assumes 4.8806% risk (volatility on return distribution) over the 90 days horizon. In different words, 43% of stocks are less volatile than Bright, and 84% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Bright Minds is expected to generate 6.43 times more return on investment than the market. However, the company is 6.43 times more volatile than its market benchmark. It trades about 0.16 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.1 per unit of risk.

Bright Minds Target Price Odds to finish over Current Price

The tendency of Bright Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 78.64 90 days 78.64 
about 38.43
Based on a normal probability distribution, the odds of Bright Minds to move above the current price in 90 days from now is about 38.43 (This Bright Minds Biosciences probability density function shows the probability of Bright Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.39 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Bright Minds will likely underperform. Additionally Bright Minds Biosciences has an alpha of 0.4684, implying that it can generate a 0.47 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Bright Minds Price Density   
       Price  

Predictive Modules for Bright Minds

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bright Minds Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bright Minds' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
73.8078.6483.48
Details
Intrinsic
Valuation
LowRealHigh
58.0762.9186.50
Details
Naive
Forecast
LowNextHigh
69.4574.2979.13
Details
6 Analysts
Consensus
LowTargetHigh
140.39154.27171.24
Details

Bright Minds Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Bright Minds is not an exception. The market had few large corrections towards the Bright Minds' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bright Minds Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bright Minds within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.47
β
Beta against Dow Jones2.39
σ
Overall volatility
13.39
Ir
Information ratio 0.11

Bright Minds Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bright Minds for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bright Minds Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Bright Minds appears to be risky and price may revert if volatility continues
Net Loss for the year was (12.23 M) with profit before overhead, payroll, taxes, and interest of 0.
Bright Minds Biosciences currently holds about 8.64 M in cash with (6.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.71.
Roughly 64.0% of the company shares are held by institutions such as insurance companies
Latest headline from globenewswire.com: Canadians Say Impaired Driving Is a Serious Public Safety Issue and Want Governments to Act

Bright Minds Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bright Stock often depends not only on the future outlook of the current and potential Bright Minds' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bright Minds' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding6.9 M
Cash And Short Term Investments82.9 M

Bright Minds Fundamentals Growth

Bright Stock prices reflect investors' perceptions of the future prospects and financial health of Bright Minds, and Bright Minds fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bright Stock performance.

About Bright Minds Performance

By analyzing Bright Minds' fundamental ratios, stakeholders can gain valuable insights into Bright Minds' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bright Minds has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bright Minds has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.13)(0.14)
Return On Capital Employed(0.15)(0.16)
Return On Assets(0.13)(0.14)
Return On Equity(0.13)(0.14)

Things to note about Bright Minds Biosciences performance evaluation

Checking the ongoing alerts about Bright Minds for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bright Minds Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Bright Minds appears to be risky and price may revert if volatility continues
Net Loss for the year was (12.23 M) with profit before overhead, payroll, taxes, and interest of 0.
Bright Minds Biosciences currently holds about 8.64 M in cash with (6.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.71.
Roughly 64.0% of the company shares are held by institutions such as insurance companies
Latest headline from globenewswire.com: Canadians Say Impaired Driving Is a Serious Public Safety Issue and Want Governments to Act
Evaluating Bright Minds' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Bright Minds' stock performance include:
  • Analyzing Bright Minds' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bright Minds' stock is overvalued or undervalued compared to its peers.
  • Examining Bright Minds' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Bright Minds' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bright Minds' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Bright Minds' stock. These opinions can provide insight into Bright Minds' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Bright Minds' stock performance is not an exact science, and many factors can impact Bright Minds' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Bright Stock analysis

When running Bright Minds' price analysis, check to measure Bright Minds' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bright Minds is operating at the current time. Most of Bright Minds' value examination focuses on studying past and present price action to predict the probability of Bright Minds' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bright Minds' price. Additionally, you may evaluate how the addition of Bright Minds to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges